Material Transfer Agreements (MTAs) are used when any biological research materials are exchanged between UTMB and another entity.
MTAs control the terms and conditions under which the recipient scientist and institution may use the exchanged materials for research. Incoming and outgoing MTAs must be reviewed and approved by the IP Legal Group. Before the materials can be sent outside UTMB, the MTA must be fully executed by all parties. Additionally, if the requested UTMB materials will be sent outside the US, then the IP Legal Group, along with the Export Control Officer, must also perform an export control review on the materials to be exchanged and the recipient.
*MTAs that involve IRB and/or clinical fees must be reviewed by the Office of Clinical Research.